About Reprosci Biosciences
Reprosci Biosciences is a Healthcare company based in Bengaluru (India) founded in 2021. Reprosci Biosciences is focused on reproductive health solutions. It operates on a HealthTech and SaaS (Software-as-a-Service) model. The company has 1 employees. Its Indian entity Reprosci Biosciences Private Limited reported revenue of ₹17.2 Lakh. Reprosci Biosciences offers products and services including Fertilator, EuLearn, and BAP C. Its focus areas include Biotechnology and Reproductive Health. Its competitors include Subhag, BendFlex and Reprosci; 1 of its 3 listed competitors has raised funding.
Company details
Reprosci Biosciences is engaged in developing futuristic solutions for reproductive health through dedicated research spanning over seven years. The company is based in Bengaluru, India, and incubated at the Center of Excellence, a joint initiative by the Ministry of Electronics and Information Technology, Government of Karnataka, and NASSCOM. Solutions are provided in regenerative medicine and medical training simulation to improve clinical outcomes in Assisted Reproductive Technology (ART) and Assisted Natural Pregnancy (ANP) treatments. The mission is set to empower healthcare professionals with metaverse training platforms and support couples through personalized biotherapeutics.
- Headquarters Bengaluru, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website reprosci.health
- Social LinkedIn Instagram
- Legal Name Reprosci Biosciences Private Limited
- Date of Incorporation 29 Nov, 2021
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹17.2 Lakh
FY 2023 · +435% YoY
- Net Loss-₹60.7 Lakh
FY 2023 · -352% margin
- EBITDA-₹54 Lakh
FY 2023 · -313% margin
- Employee Count1
Associated legal entities of Reprosci Biosciences
Reprosci Biosciences operates through Reprosci Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Reprosci Biosciences Private Limited CIN U85100KA2021PTC154968 | Active | 29 Nov 2021 | Bangalore, Karnataka | ₹0.2 Cr | 4 | View details |
Products & Services of Reprosci Biosciences
Reprosci Biosciences offers a comprehensive portfolio of products and services, including Fertilator, EuLearn, and BAP C.
Fertilator is used for IVF training and simulation.
EuLearn is utilized for online and hybrid learning.
BAP C is developed for reproductive health solutions.
Board of directors of Reprosci Biosciences Private Limited (Reprosci Biosciences)
Reprosci Biosciences Private Limited is the primary company behind Reprosci Biosciences. The board of Reprosci Biosciences Private Limited currently have 4 directors; the longest-serving is Sejal Ullas Shah, appointed in 2021. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sejal Ullas Shah DIN 08096024 | Director | 29 Nov 2021 | 4 yrs 10 mo | Reprosci Biosciences Private Limited |
| Mahendra Budharam Narwaria DIN 02174084 | Director | 29 Nov 2021 | 4 yrs 10 mo | Reprosci Biosciences Private Limited |
| Ravi Shankar Swamy DIN 08536314 | Director | 24 Dec 2021 | 4 yrs 10 mo | Reprosci Biosciences Private Limited |
| Ketul Pragneshkumar Patel DIN 03511749 | Director | 02 Aug 2023 | 3 yrs 2 mo | Reprosci Biosciences Private Limited |
Financials of Reprosci Biosciences
Figures of Reprosci Biosciences Private Limited, the primary company behind Reprosci Biosciences, for FY 2023. Revenue was ₹17.2 Lakh (+435% year on year). Net loss was -₹60.7 Lakh (-352% margin). EBITDA was -₹54 Lakh (-313% margin).
- ₹17.2 LakhRevenue · FY 2023 · +435% YoY
- -₹60.7 LakhNet loss · -352% margin
- -₹54 LakhEBITDA · -313% margin
- ₹14.2 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Reprosci Biosciences Private Limited are on its company page.
Detailed financial statements for Reprosci Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Reprosci Biosciences
Reprosci Biosciences has 3 listed competitors in our database, 1 of them funded. They include Subhag, BendFlex and Reprosci.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| subhag.in | 2018 | Bengaluru, India | $693,929 | Infertility treatment devices are developed with patented technology. | ||
| bendflex.in | 2015 | Bengaluru, India | A medical device is developed to enhance IVF success rates. | |||
| reprosci.com | 2021 | Bengaluru, India | Medical training simulators, learning platforms, and AI/ML solutions are developed. |
Detailed competitors of Reprosci Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Reprosci Biosciences
Reprosci Biosciences was founded in 2021.
Reprosci Biosciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Reprosci Biosciences has 1 employees.
The primary company behind Reprosci Biosciences, Reprosci Biosciences Private Limited, reported revenue of ₹17.2 Lakh for FY 2023, up 435% year on year.
Reprosci Biosciences is engaged in developing futuristic solutions for reproductive health through dedicated research spanning over seven years. The company is based in Bengaluru, India, and incubated at the Center of Excellence, a joint initiative by the Ministry of Electronics and Information Technology, Government of Karnataka, and NASSCOM. Solutions are provided in regenerative medicine and medical training simulation to improve clinical outcomes in Assisted Reproductive Technology (ART) and Assisted Natural Pregnancy (ANP) treatments. The mission is set to empower healthcare professionals with metaverse training platforms and support couples through personalized biotherapeutics.
Reprosci Biosciences offers Fertilator, EuLearn, and BAP C.
Reprosci Biosciences operates through Reprosci Biosciences Private Limited.
The legal entities of Reprosci Biosciences currently have 4 directors, including Sejal Ullas Shah, Ketul Pragneshkumar Patel, Ravi Shankar Swamy and others.